Katarina Steding-Ehrenborg, Anders Nelsson, Henrik Engblom, Ellen Ostenfeld, Per M Arvidsson, Martin Magnusson, J Gustav Smith, Håkan Arheden
{"title":"Low peak oxygen uptake in relation to total heart volume as an early marker of sub-clinical diastolic dysfunction.","authors":"Katarina Steding-Ehrenborg, Anders Nelsson, Henrik Engblom, Ellen Ostenfeld, Per M Arvidsson, Martin Magnusson, J Gustav Smith, Håkan Arheden","doi":"10.1093/ehjimp/qyaf115","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Peak oxygen uptake (VO<sub>2</sub>peak) is closely related to total heart volume (THV) in healthy individuals. This study aimed to investigate (i) the association between VO<sub>2</sub>peak and THV in subjects with sub-clinical diastolic dysfunction, athletes, healthy controls, and patients with established heart failure with and without preserved ejection fraction (HFpEF and HFrEF), and (ii) whether VO<sub>2</sub>peak/THV-index can distinguish between subjects with sub-clinical diastolic dysfunction, HFpEF, HFrEF, and healthy controls.</p><p><strong>Methods and results: </strong>Seventy participants were included: 15 with sub-clinical diastolic dysfunction (defined as showing only 1-2 echocardiographic signs of diastolic dysfunction, not meeting clinical diagnostic criteria), 10 athletes, 15 healthy controls, and 30 heart failure patients (15 HFpEF and 15 HFrEF). VO<sub>2</sub>peak was assessed by cardiopulmonary exercise testing and THV by cardiovascular magnetic resonance imaging. In sub-clinical diastolic dysfunction, THV was a weak determinant of VO<sub>2</sub>peak (<i>R</i> <sup>2</sup> = 0.41, <i>P</i> = 0.01), and even weaker in heart failure (<i>R</i> <sup>2</sup> = 0.16, <i>P</i> = 0.03). However, THV strongly predicted VO<sub>2</sub>peak in athletes and controls combined (<i>R</i> <sup>2</sup> = 0.87, <i>P</i> < 0.0001). VO<sub>2</sub>peak/THV did not distinguish healthy controls from sub-clinical diastolic dysfunction but could reliably discriminate between healthy controls and patients with heart failure.</p><p><strong>Conclusion: </strong>Subjects with sub-clinical diastolic dysfunction may have an altered relationship between VO<sub>2</sub>peak and THV, approaching that of patients with established heart failure. Thus, this proof-of-concept study indicates that sub-clinical diastolic dysfunction constitutes a group of patients that may be of interest to follow over time to prevent continued deterioration of cardiac function. Furthermore, the VO<sub>2</sub>peak/THV ratio can be used to distinguish between healthy controls and overt heart failure.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf115"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12459250/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal. Imaging methods and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjimp/qyaf115","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: Peak oxygen uptake (VO2peak) is closely related to total heart volume (THV) in healthy individuals. This study aimed to investigate (i) the association between VO2peak and THV in subjects with sub-clinical diastolic dysfunction, athletes, healthy controls, and patients with established heart failure with and without preserved ejection fraction (HFpEF and HFrEF), and (ii) whether VO2peak/THV-index can distinguish between subjects with sub-clinical diastolic dysfunction, HFpEF, HFrEF, and healthy controls.
Methods and results: Seventy participants were included: 15 with sub-clinical diastolic dysfunction (defined as showing only 1-2 echocardiographic signs of diastolic dysfunction, not meeting clinical diagnostic criteria), 10 athletes, 15 healthy controls, and 30 heart failure patients (15 HFpEF and 15 HFrEF). VO2peak was assessed by cardiopulmonary exercise testing and THV by cardiovascular magnetic resonance imaging. In sub-clinical diastolic dysfunction, THV was a weak determinant of VO2peak (R2 = 0.41, P = 0.01), and even weaker in heart failure (R2 = 0.16, P = 0.03). However, THV strongly predicted VO2peak in athletes and controls combined (R2 = 0.87, P < 0.0001). VO2peak/THV did not distinguish healthy controls from sub-clinical diastolic dysfunction but could reliably discriminate between healthy controls and patients with heart failure.
Conclusion: Subjects with sub-clinical diastolic dysfunction may have an altered relationship between VO2peak and THV, approaching that of patients with established heart failure. Thus, this proof-of-concept study indicates that sub-clinical diastolic dysfunction constitutes a group of patients that may be of interest to follow over time to prevent continued deterioration of cardiac function. Furthermore, the VO2peak/THV ratio can be used to distinguish between healthy controls and overt heart failure.